{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Pyrazole", "anti-inflammatory", "khellin", "pyrazolylpyrazoline"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33813964", "DateCompleted": {"Year": "2022", "Month": "06", "Day": "02"}, "DateRevised": {"Year": "2022", "Month": "06", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "04", "Day": "05"}], "Language": ["eng"], "ELocationID": ["10.1080/14786419.2021.1907383"], "Journal": {"ISSN": "1478-6427", "JournalIssue": {"Volume": "36", "Issue": "10", "PubDate": {"Year": "2022", "Month": "May"}}, "Title": "Natural product research", "ISOAbbreviation": "Nat Prod Res"}, "ArticleTitle": "Non-ulcerogenic pyrazolyl 2-hydroxychalcones and pyrazolylpyrazolines derived from naturally existing furochromone (khellin): semi-synthesis, docking study and anti-inflammatory activity.", "Pagination": {"StartPage": "2486", "EndPage": "2494", "MedlinePgn": "2486-2494"}, "Abstract": {"AbstractText": ["Novel pyrazolyl 2-hydroxychalcone derivatives <b>3a-e</b> and pyrazolylpyrazoline derivatives <b>4a-e</b> and <b>5a-j</b> derived from the naturally existing furochromone (Khellin) were synthesized and evaluated for their <i>in\u00a0vivo</i> anti-inflammatory activity. Most of the synthesized compounds showed better or comparable activity to that of Diclofenac as reference drug. Twelve compounds were evaluated for their ulcerogenic potential and exhibited no ulcerogenic effect. In addition compounds <b>3c</b>, <b>5c</b> and <b>5h</b> as examples showed PGE<sub>2</sub> inhibition % 88.86, 65.87 and 44.06, respectively and TNF\u03b1 inhibition % 48.62, 31.11 and 16.02, respectively in rat serum samples. Compounds <b>3c</b>, <b>5c</b>, <b>5h</b> and Celecoxib were subjected to <i>in\u00a0vitro</i> COX-1 and COX-2 inhibition assay, showed selectivity index 45.04, 102.04, 131.58 and 185.18, respectively. The computational finding supported those of <i>in\u00a0vitro</i>, where the pyrazolylpyrazolines interacted with the COX-2 enzyme in a similar orientation to that of Celecoxib, while chlacones were found to exhibit similar orientation to that of Diclofenac."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt."}], "LastName": "Ragab", "ForeName": "Fatma Abd El-Fattah", "Initials": "FAE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt."}, {"Identifier": [], "Affiliation": "Pharmaceutical Chemistry Department, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza, Egypt."}], "LastName": "Nissan", "ForeName": "Yassin Mohammed", "Initials": "YM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Chemistry Department, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza, Egypt."}, {"Identifier": [], "Affiliation": "School of Life and Medical Sciences, University of Hertfordshire hosted by Global Academic Foundation, New Administrative Capital, Cairo, Egypt."}], "LastName": "Salem", "ForeName": "M Alaraby", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biochemistry Department, Genetic Engineering and Biotechnology Research Division, National Research Centre, Giza, Egypt."}], "LastName": "Ali", "ForeName": "Mamdouh Moawad", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants Department, Desert Research Centre, Cairo, Egypt."}], "LastName": "Selim", "ForeName": "Ahmed Abbass Mohamed Abdelrahman", "Initials": "AAMA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Nat Prod Res", "NlmUniqueID": "101167924", "ISSNLinking": "1478-6419"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclooxygenase 2 Inhibitors"}, {"RegistryNumber": "144O8QL0L1", "NameOfSubstance": "Diclofenac"}, {"RegistryNumber": "5G117T0TJZ", "NameOfSubstance": "Khellin"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Cyclooxygenase 2"}, {"RegistryNumber": "JCX84Q7J1L", "NameOfSubstance": "Celecoxib"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Celecoxib"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclooxygenase 2"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cyclooxygenase 2 Inhibitors"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Diclofenac"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Edema"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Khellin"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2021", "Month": "4", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "5", "Hour": "5", "Minute": "24"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33813964", "10.1080/14786419.2021.1907383"]}}], "PubmedBookArticle": []}